Hikma Pharma Reaffirms FY25 Guidance Amid Strong Start
24/4 08:53
(RTTNews) - Hikma Pharmaceuticals Plc (HIK, HIK.L), on Thursday, reiterated its full-year guidance following a solid start to 2025, highlighting strong performance across its core business segments....